The Sexually Transmitted Disease (STD) Testing Market is being driven by Increasing prevalence of STDs
The Sexually Transmitted Disease (STD) Testing Market is expected to grow at a CAGR of 5.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 32.37 billion. The Sexually Transmitted Disease (STD) testing market is experiencing a notable transition from conventional laboratory testing towards rapid point-of-care (POC) testing. POC HIV testing, in particular, has gained widespread acceptance due to its ability to surmount patient and provider barriers to routine screening. The preference for self-testing for HIV, as evidenced by home HIV test kits or self-testing in a home setting, is on the rise in developed countries. POC testing's efficacy is further amplified by the advancements in sensors, microsystems, and affordable imaging technologies. Additionally, the market is witnessing swift progress in molecular diagnostics used for STDs testing.
Get more information on Sexually Transmitted Disease (STD) Testing Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
176 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.6% |
|
Market growth 2024-2028 |
USD 32.37 billion |
|
Market structure |
fragmentation |
|
YoY growth 2023-2024(%) |
5.22 |
|
Key countries |
US, Canada, Germany, UK, Italy, France, China, India, Japan, Brazil, Egypt, UAE, Oman, Argentina, KSA, UAE, Brazil, Rest of World (ROW), US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Sexually Transmitted Disease (STD) Testing Market encompasses various diagnostic technologies and methods for the detection of STDs. These include PCR testing technology and NAAT testing platforms for the identification of Chlamydia and Gonorrhea. Syphilis is diagnosed through serology tests, such as immunofluorescence assays and Western blot techniques. HPV DNA testing, Hepatitis B and C testing, Trichomonas detection, and bacterial culture methods with microscopy techniques are also utilized. Viral load measurement, test kit validation, quality control measures, laboratory accreditation, and specimen handling procedures ensure accurate results. Data management systems, diagnostic algorithms, clinical interpretation, treatment efficacy monitoring, disease outbreak investigation, health disparities research, preventive healthcare access, community health programs, and risk reduction interventions are essential components of effective STD testing and control strategies.
The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of various product categories, including rapid diagnostic tests such as ELISA testing methods, point-of-care diagnostics, antibody detection assays, and antigen detection assays. These tools are essential for the pharmaceutical and biotechnology industries, as well as laboratory diagnosis of diseases. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. Factors driving growth in this market include the increasing global population aging, resulting in a larger demographic requiring healthcare solutions, and the subsequent rise in demand for advanced diagnostic tools, particularly in the area of sexually transmitted diseases (STDs). These diagnostic tools, including rapid STD tests, are crucial for early detection and treatment, ultimately improving patient outcomes and reducing the spread of these diseases.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
